Cyclerion Therapeutics, Inc. ( CYCN) - Key Metrics
Stock symbol CYCN is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker CYCN was renamed to
KRSA
effective 2026-09-09.
CYCN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.41 | -$0.34 | -$0.32 |
| 2026Q1 | $0 | -$0.76 | -$0.28 | -$0.30 |
| 2025Q4 | $0.32 | -$0.25 | -$0.49 | -$0.49 |
| 2025Q3 | $0.27 | -$0.30 | -$0.08 | -$0.08 |
| 2025Q2 | $0.03 | -$0.11 | -$0.16 | -$0.16 |
CYCN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.07 |
| 2026Q1 | 0% | -0.51 |
| 2025Q4 | 0% | -1.27 |
| 2025Q3 | 0% | -1.92 |
| 2025Q2 | 0% | -6.61 |
CYCN
Price: $23.52
52 week price:
Earnings Per Share: -1.66 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 146600
Market Capitalization: 23.2 million